Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy's Holding Period [Yahoo! Finance]
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
VITAS® Healthcare Is First Hospice Organization to Earn American Heart Association Heart Failure Certification Across All 15 States and DC [Yahoo! Finance]
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $633.00 to $667.00. They now have an "outperform" rating on the stock.
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.